Centiva Capital’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$172K Sell
39,785
-10,934
-22% -$47.8K ﹤0.01% 1444
2026
Q1
$195K Buy
50,719
+30,538
+151% +$125K ﹤0.01% 1283
2025
Q4
$74.9K Buy
+20,181
New +$173K ﹤0.01% 1110
2024
Q3
Sell
-1,113
Closed -$64.3K 2473
2024
Q2
$64.3K Buy
+1,113
New +$54.5K ﹤0.01% 1903
2024
Q1
Sell
-1,811
Closed -$147K 2101
2023
Q4
$147K Buy
+1,811
New +$147K ﹤0.01% 1513

Other funds holding OM

Centiva Capital's OM Position: Q2 2026 in Review

Centiva Capital reduced its Outset Medical (OM) stake by 22% in Q2 2026, selling an estimated $47.8K and leaving 39,785 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

Centiva Capital first reported a position in OM in Q4 2023 and has held it in 5 quarters since. The position peaked at $195K in Q1 2026. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Centiva Capital held 39,785 shares of Outset Medical worth $172K as of Q2 2026.
  • Centiva Capital sold 10,934 Outset Medical shares in Q2 2026, an estimated $47.8K.
  • Outset Medical made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1444 holding.
  • Centiva Capital first reported a position in Outset Medical in Q4 2023 and has held it in 5 quarters since.
  • Centiva Capital's Outset Medical position peaked at $195K in Q1 2026.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.